Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia

References

1. ↵
   1. Melmed S,
   2. Polonsky K,
   3. Larsen PR,
   4. Kronenberg H

   (2011) Williams textbook of endocrinology (Elsevier/Saunders, Philadelphia (PA)), 12th ed, pp 1371–1435.
2. ↵
   1. Whiting DR,
   2. Guariguata L,
   3. Weil C,
   4. Shaw J

   (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321.

   OpenUrlCrossRefPubMed
3. ↵
   1. Shi Y,
   2. Hu FB

   (2014) The global implications of diabetes and cancer. Lancet 383:1947–1948.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Al-Quwaidhi AJ,
   2. Pearce MS,
   3. Sobngwi E,
   4. Critchley JA,
   5. O’Flaherty M

   (2014) Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies. Diabetes Res Clin Pract 103:496–503.

   OpenUrl
5. ↵
   1. International Diabetes Federation

   IDF Diabetes Atlas, Available from URL: http://www.diabetesatlas.org/. [Updated 2014, Accessed 2015 May 16]. 7th ed.
6. ↵
   1. Dormandy JA,
   2. Charbonnel B,
   3. Eckland DJ,
   4. Erdmann E,
   5. Massi-Benedetti M,
   6. Moules IK,
   7. et al.

   (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366:1279–1289.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Aiello LP,
   2. Gardner TW,
   3. King GL,
   4. Blankenship G,
   5. Cavallerano JD,
   6. Ferris FL 3rd.,
   7. et al.

   (1998) Diabetic retinopathy. Diabetes care 21:143–156.

   OpenUrlFREE Full Text
8. ↵
   1. Diabetes.co.uk. Diabetes complications

   , Available from: http://www.diabetes.co.uk/diabetes-complications/diabetes-complications.html. [Updated 2015; Accessed 2015 May 24/].
9. ↵
   (2014) Standards of Medical Care in Diabetes. Diabetes Care 37:14–80.

   OpenUrlCrossRef
10. ↵
    1. Khan AR,
    2. Wiseberg JA,
    3. Lateef ZAA,
    4. Khan SA

    (2010) Prevalence and Determinants of Diabetic Retinopathy in Al Hasa Region of Saudi Arabia: Primary Health Care Centre Based Cross-Sectional Survey 2007-2009. Middle East Afr J Ophthalmol 17:257–263.

    OpenUrlPubMed
11. ↵
    1. Kang ES,
    2. Kim HJ,
    3. Ahn CW,
    4. Park CW,
    5. Cha BS,
    6. Lim SK,
    7. et al.

    (2005) Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Res Clin Pract 69:151–159.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Stratton IM,
    2. Adler AI,
    3. Neil HAW,
    4. Matthews DR,
    5. Manley SE,
    6. Cull CA,
    7. et al.

    Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 405–412.
13. ↵
    1. Avogaro A,
    2. Giorda C,
    3. Maggini M,
    4. Mannucci E,
    5. Raschetti R,
    6. Lombardo F,
    7. et al.

    (2007) Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 30:1241–1247.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Micha R,
    2. Khatibzadeh S,
    3. Shi P,
    4. Fahimi S,
    5. Lim S,
    6. Andrews KG,
    7. et al.

    (2014) Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 348:g2272.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Malandrino N,
    2. Wu WC,
    3. Taveira TH,
    4. Whitlatch HB,
    5. Smith RJ

    (2012) Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 55:226–235.

    OpenUrlCrossRefPubMedWeb of Science
16. 1. Nathan DM

    (2014) The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37:9–16.

    OpenUrlAbstract/FREE Full Text
17. ↵
    1. Kim JH,
    2. Kim DJ,
    3. Jang HC,
    4. Choi SH

    (2011) Epidemiology of micro- and macrovascular complications of type 2 diabetes in Korea. Diabetes & Metabolism Journal 35:571–577.

    OpenUrl
18. ↵
    1. Bril V,
    2. Tomioka S,
    3. Buchanan RA,
    4. Perkins BA

    (2009) the m TSG. Reliability and validity of the modified Toronto clinical neuropathy score in diabetic sensorimotor polyneuropathy. Diabetic Medicine 26:240–246.

    OpenUrlCrossRefPubMed